# Ma Ke

> Ma Ke is a Series B investor at CBC Group backing Health Care and Therapeutics. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [CBC Group](https://shizune.co/investors/profile/cbc-group-465a)
- Total investments: 1
- Last investment: Aug 2022
- Lead investor: 100%
- Last updated: Aug 2026

Ma Ke is a Series B investor at CBC Group focused on Health Care and Therapeutics. Ma Ke is working as Managing Director for CBC Cambridge Capital.

## Contacts

5 contacts available for Ma Ke: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/ma-ke?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hunan Yiyi Pharmaceutical Technology | Hunan Yiyi Pharmaceutical Technology |  | Series B | Aug 31, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Cenova](https://shizune.co/investors/profile/cenova-ventures) — VC Fund, 1 deal together
- [Unicorn Capital Partners](https://shizune.co/investors/profile/unicorn-capital-partners-0f14) — VC Fund, 1 deal together

## About CBC Group

VC Fund

CBC Group is a healthcare-dedicated investment firm that creates value and integrates global resources.

4 contacts available at CBC Group.

| Name | Title | Profile |
| --- | --- | --- |
| Kerry Blanchard | Operating Partner | https://shizune.co/investors/profile/kerry-blanchard |
| Lincoln Chee Wang Jin | Managing Director | https://shizune.co/investors/profile/lincoln-chee-wang-jin |
| Ma Ke | Managing Director | — |
| Sean Cao | Managing Director | — |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Ma Ke invest in?

Ma Ke invests primarily in Health Care, Therapeutics and Pharmaceutical startups, most often at Series B stage. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Ma Ke?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Ma Ke last invest?

The most recent investment recorded for Ma Ke closed in Aug 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co